WASHINGTON (Reuters) - When U.S. President Lyndon B. Johnson took the stage at Howard University in June of 1965, he had already signed the Civil Rights act into law, and he said he expected to sign ...

To maintain grasslands nevertheless, "prescribed" burning, which is what land managers call controlled burning, is being discussed as a labor-efficient option. But not all grasslands are equal.

Roosevelt and Lyndon B. Johnson, arguing that for all four of them, “at some point, ambition for… The Tet Offensive began in stealth 50 years ago in Vietnam, but it ended up splashed on ...

Dedicated to the 36th president of the United States, the Lyndon B. Johnson Presidential Library houses all the expected artifacts – such as presidential papers – as well as several quirkier ...

Bryan Johnson has dropped the medicine he had been taking for last five years. Bryan Johnson, the 47-year-old tech entrepreneur who has spent millions on his quest to reverse his biological age ...

Gabby Jones / Bloomberg / Getty Images Johnson & Johnson is scheduled to report fourth-quarter earnings Wednesday morning, with analysts expecting sales and profits to grow year-over-year.

Supported by operational growth of 6.7%, Johnson & Johnson (JNJ, Financials) reported a 5.3% rise in fourth-quarter revenues to $22.5 billion. With operational growth of 5.9% except for COVID-19 ...

It’s nearly a year and a half since Johnson & Johnson split off its consumer-health arm to focus on pharmaceuticals and medical technology. Johnson & Johnson has wasted no time expanding its ...

Johnson & Johnson (JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to about $143 per share. Several negative impacts were highlighted in the ...

Diontae Johnson's 2024 odyssey has reached another twist. The Texans waived Johnson on Tuesday, the team announced. "With Diontae, unfortunately it didn't work out and we're on to the Chiefs ...

Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s ...

Johnson & Johnson (NYSE:JNJ) is scheduled to announce Q4 earnings results on Wednesday, January 22nd, before market open. Analysts expect a profit per share of $2.02, which is a decline of 11.8% ...